Handbook of Biomarkers and Precision Medicine

"The field of Biomarkers and Precision Medicine in drug development is rapidly evolving and this book presents a snapshot of exciting new approaches. By presenting a wide range of biomarker applications, discussed by knowledgeable and experienced scientists, readers will develop an appreciation of the scope and breadth of biomarker knowledge and find examples that will help them in their own work." - Maria Freire, Foundation for the National Institutes of Health

Handbook of Biomarkers and Precision Medicine provides comprehensive insights into biomarker discovery and development which has driven the new era of Precision Medicine. A wide variety of renowned experts from government, academia, teaching hospitals, biotechnology, and pharmaceutical companies share best practices, examples, and exciting new developments. The handbook aims to provide in-depth knowledge to research scientists, students, and decision-makers engaged in Biomarker and Precision Medicine-centric drug development.

Features:

• Detailed insights into biomarker discovery, validation, and diagnostic development with implementation strategies.
• Lessons-learned from successful Precision Medicine case studies.
• A variety of exciting and emerging biomarker technologies.
• The next frontiers and future challenges of biomarkers in Precision Medicine.

Claudio Carini, Mark Fidock, and Alain van Gool are internationally recognised as scientific leaders in Biomarkers and Precision Medicine. They have worked for decades in academia and the pharmaceutical industry in the EU, USA, and Asia. Currently, Dr. Carini is Honorary Faculty at King’s College School of Medicine, London, UK. Dr. Fidock is Vice President of Precision Medicine Laboratories at AstraZeneca, Cambridge, UK. Prof. dr. van Gool is Head of the Translational Metabolic Laboratory at Radboud university medical school, Nijmegen, NL.